Medical Device News Magazine

Circular Genomics Finalizes Exclusive IP Licenses with Leading Global Research Institutions to Advance circRNA Blood Test for Alzheimer’s Disease

Agreements strengthen proprietary foundation, enhance partnering readiness, and support regulatory [...]

By |2026-02-10T14:07:35+00:00February 10, 2026|3rd Party Medical Device Industry News|Comments Off on Circular Genomics Finalizes Exclusive IP Licenses with Leading Global Research Institutions to Advance circRNA Blood Test for Alzheimer’s Disease
Go to Top